- Home
- ANTX vs PCQ Comparison
ANTX vs PCQ Comparison
Compare ANTX & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | PCQ |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 165.1M |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ANTX | PCQ |
|---|---|---|
| Price | $3.58 | $8.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 296.8K | ★ 308.4K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.63% |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $7.57 |
| 52 Week High | $7.19 | $9.19 |
Technical Indicators
Market Signals| Indicator | ANTX | PCQ |
|---|---|---|
| Relative Strength Index (RSI) | 30.50 | 53.31 |
| Support Level | $3.21 | N/A |
| Resistance Level | $5.15 | $9.16 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 19.73 | 92.86 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About PCQ PIMCO California Municipal Income Fund
PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal, New York State, and New York City income tax. The fund invests across sectors including healthcare, property, education, Natural Gas, and others.